Medical Care
Digital Therapeutics for Nervous System Diseases - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Oct 06, 24
- ID: 595300
- Pages: 114
- Figures: 183
- Views: 9
Digital Therapeutics for Nervous System Diseases are software program-driven, evidence-based interventions to treat, manage, or prevent nervous system diseases.
The global market for Digital Therapeutics for Nervous System Diseases was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Digital Therapeutics for Nervous System Diseases include Zoecare, 66nao, MedRhythms, Curelator, Sanofi, GYENNO SCIENCE, Cognito Therapeutics, Nanjing Vishee Medical Technology Co.,Ltd. and Glecan, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Nervous System Diseases, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digital Therapeutics for Nervous System Diseases by region & country, by Type, and by Application.
The Digital Therapeutics for Nervous System Diseases market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Nervous System Diseases.
Market Segmentation
By Company
Zoecare
66nao
MedRhythms
Curelator
Sanofi
GYENNO SCIENCE
Cognito Therapeutics
Nanjing Vishee Medical Technology Co.,Ltd.
Glecan
Xinkangyx
WonderLab
BestCovered, Ltd.
Segment by Type:
Prevention
Management
Treatment
Segment by Application
Epilepsy
Parkinson's Disease
Alzheimer's Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digital Therapeutics for Nervous System Diseases manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digital Therapeutics for Nervous System Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digital Therapeutics for Nervous System Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global market for Digital Therapeutics for Nervous System Diseases was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Digital Therapeutics for Nervous System Diseases was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Digital Therapeutics for Nervous System Diseases include Zoecare, 66nao, MedRhythms, Curelator, Sanofi, GYENNO SCIENCE, Cognito Therapeutics, Nanjing Vishee Medical Technology Co.,Ltd. and Glecan, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Digital Therapeutics for Nervous System Diseases, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Digital Therapeutics for Nervous System Diseases by region & country, by Type, and by Application.
The Digital Therapeutics for Nervous System Diseases market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Therapeutics for Nervous System Diseases.
Market Segmentation
By Company
Zoecare
66nao
MedRhythms
Curelator
Sanofi
GYENNO SCIENCE
Cognito Therapeutics
Nanjing Vishee Medical Technology Co.,Ltd.
Glecan
Xinkangyx
WonderLab
BestCovered, Ltd.
Segment by Type:
Prevention
Management
Treatment
Segment by Application
Epilepsy
Parkinson's Disease
Alzheimer's Disease
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Digital Therapeutics for Nervous System Diseases manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Digital Therapeutics for Nervous System Diseases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Digital Therapeutics for Nervous System Diseases in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Digital Therapeutics for Nervous System Diseases Product Introduction
1.2 Global Digital Therapeutics for Nervous System Diseases Market Size Forecast
1.3 Digital Therapeutics for Nervous System Diseases Market Trends & Drivers
1.3.1 Digital Therapeutics for Nervous System Diseases Industry Trends
1.3.2 Digital Therapeutics for Nervous System Diseases Market Drivers & Opportunity
1.3.3 Digital Therapeutics for Nervous System Diseases Market Challenges
1.3.4 Digital Therapeutics for Nervous System Diseases Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digital Therapeutics for Nervous System Diseases Players Revenue Ranking (2023)
2.2 Global Digital Therapeutics for Nervous System Diseases Revenue by Company (2019-2024)
2.3 Key Companies Digital Therapeutics for Nervous System Diseases Manufacturing Base Distribution and Headquarters
2.4 Key Companies Digital Therapeutics for Nervous System Diseases Product Offered
2.5 Key Companies Time to Begin Mass Production of Digital Therapeutics for Nervous System Diseases
2.6 Digital Therapeutics for Nervous System Diseases Market Competitive Analysis
2.6.1 Digital Therapeutics for Nervous System Diseases Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Digital Therapeutics for Nervous System Diseases Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prevention
3.1.2 Management
3.1.3 Treatment
3.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Type
3.2.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Type (2019-2030)
3.2.3 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Epilepsy
4.1.2 Parkinson's Disease
4.1.3 Alzheimer's Disease
4.1.4 Other
4.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Application
4.2.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Application (2019-2030)
4.2.3 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region
5.1.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024)
5.1.3 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030)
5.1.4 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.2.2 North America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.3.2 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.4.2 Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.5.2 South America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.6.2 Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value
6.3 United States
6.3.1 United States Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.3.2 United States Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.4.2 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.5.2 China Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.6.2 Japan Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.7.2 South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.8.2 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.9.2 India Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoecare
7.1.1 Zoecare Profile
7.1.2 Zoecare Main Business
7.1.3 Zoecare Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.1.4 Zoecare Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.1.5 Zoecare Recent Developments
7.2 66nao
7.2.1 66nao Profile
7.2.2 66nao Main Business
7.2.3 66nao Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.2.4 66nao Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.2.5 66nao Recent Developments
7.3 MedRhythms
7.3.1 MedRhythms Profile
7.3.2 MedRhythms Main Business
7.3.3 MedRhythms Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.3.4 MedRhythms Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.3.5 Curelator Recent Developments
7.4 Curelator
7.4.1 Curelator Profile
7.4.2 Curelator Main Business
7.4.3 Curelator Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.4.4 Curelator Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.4.5 Curelator Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.5.4 Sanofi Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 GYENNO SCIENCE
7.6.1 GYENNO SCIENCE Profile
7.6.2 GYENNO SCIENCE Main Business
7.6.3 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.6.4 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.6.5 GYENNO SCIENCE Recent Developments
7.7 Cognito Therapeutics
7.7.1 Cognito Therapeutics Profile
7.7.2 Cognito Therapeutics Main Business
7.7.3 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.7.4 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.7.5 Cognito Therapeutics Recent Developments
7.8 Nanjing Vishee Medical Technology Co.,Ltd.
7.8.1 Nanjing Vishee Medical Technology Co.,Ltd. Profile
7.8.2 Nanjing Vishee Medical Technology Co.,Ltd. Main Business
7.8.3 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.8.4 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.8.5 Nanjing Vishee Medical Technology Co.,Ltd. Recent Developments
7.9 Glecan
7.9.1 Glecan Profile
7.9.2 Glecan Main Business
7.9.3 Glecan Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.9.4 Glecan Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.9.5 Glecan Recent Developments
7.10 Xinkangyx
7.10.1 Xinkangyx Profile
7.10.2 Xinkangyx Main Business
7.10.3 Xinkangyx Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.10.4 Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.10.5 Xinkangyx Recent Developments
7.11 WonderLab
7.11.1 WonderLab Profile
7.11.2 WonderLab Main Business
7.11.3 WonderLab Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.11.4 WonderLab Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.11.5 WonderLab Recent Developments
7.12 BestCovered, Ltd.
7.12.1 BestCovered, Ltd. Profile
7.12.2 BestCovered, Ltd. Main Business
7.12.3 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.12.4 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.12.5 BestCovered, Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Digital Therapeutics for Nervous System Diseases Industrial Chain
8.2 Digital Therapeutics for Nervous System Diseases Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digital Therapeutics for Nervous System Diseases Sales Model
8.5.2 Sales Channel
8.5.3 Digital Therapeutics for Nervous System Diseases Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Digital Therapeutics for Nervous System Diseases Product Introduction
1.2 Global Digital Therapeutics for Nervous System Diseases Market Size Forecast
1.3 Digital Therapeutics for Nervous System Diseases Market Trends & Drivers
1.3.1 Digital Therapeutics for Nervous System Diseases Industry Trends
1.3.2 Digital Therapeutics for Nervous System Diseases Market Drivers & Opportunity
1.3.3 Digital Therapeutics for Nervous System Diseases Market Challenges
1.3.4 Digital Therapeutics for Nervous System Diseases Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Digital Therapeutics for Nervous System Diseases Players Revenue Ranking (2023)
2.2 Global Digital Therapeutics for Nervous System Diseases Revenue by Company (2019-2024)
2.3 Key Companies Digital Therapeutics for Nervous System Diseases Manufacturing Base Distribution and Headquarters
2.4 Key Companies Digital Therapeutics for Nervous System Diseases Product Offered
2.5 Key Companies Time to Begin Mass Production of Digital Therapeutics for Nervous System Diseases
2.6 Digital Therapeutics for Nervous System Diseases Market Competitive Analysis
2.6.1 Digital Therapeutics for Nervous System Diseases Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Digital Therapeutics for Nervous System Diseases Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Prevention
3.1.2 Management
3.1.3 Treatment
3.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Type
3.2.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Type (2019-2030)
3.2.3 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Epilepsy
4.1.2 Parkinson's Disease
4.1.3 Alzheimer's Disease
4.1.4 Other
4.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Application
4.2.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Application (2019-2030)
4.2.3 Global Digital Therapeutics for Nervous System Diseases Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region
5.1.1 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024)
5.1.3 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030)
5.1.4 Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.2.2 North America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.3.2 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.4.2 Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.5.2 South America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
5.6.2 Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value
6.3 United States
6.3.1 United States Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.3.2 United States Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.4.2 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.5.2 China Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.5.3 China Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.6.2 Japan Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.7.2 South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.8.2 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Digital Therapeutics for Nervous System Diseases Sales Value, 2019-2030
6.9.2 India Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
6.9.3 India Digital Therapeutics for Nervous System Diseases Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Zoecare
7.1.1 Zoecare Profile
7.1.2 Zoecare Main Business
7.1.3 Zoecare Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.1.4 Zoecare Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.1.5 Zoecare Recent Developments
7.2 66nao
7.2.1 66nao Profile
7.2.2 66nao Main Business
7.2.3 66nao Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.2.4 66nao Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.2.5 66nao Recent Developments
7.3 MedRhythms
7.3.1 MedRhythms Profile
7.3.2 MedRhythms Main Business
7.3.3 MedRhythms Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.3.4 MedRhythms Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.3.5 Curelator Recent Developments
7.4 Curelator
7.4.1 Curelator Profile
7.4.2 Curelator Main Business
7.4.3 Curelator Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.4.4 Curelator Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.4.5 Curelator Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.5.4 Sanofi Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 GYENNO SCIENCE
7.6.1 GYENNO SCIENCE Profile
7.6.2 GYENNO SCIENCE Main Business
7.6.3 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.6.4 GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.6.5 GYENNO SCIENCE Recent Developments
7.7 Cognito Therapeutics
7.7.1 Cognito Therapeutics Profile
7.7.2 Cognito Therapeutics Main Business
7.7.3 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.7.4 Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.7.5 Cognito Therapeutics Recent Developments
7.8 Nanjing Vishee Medical Technology Co.,Ltd.
7.8.1 Nanjing Vishee Medical Technology Co.,Ltd. Profile
7.8.2 Nanjing Vishee Medical Technology Co.,Ltd. Main Business
7.8.3 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.8.4 Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.8.5 Nanjing Vishee Medical Technology Co.,Ltd. Recent Developments
7.9 Glecan
7.9.1 Glecan Profile
7.9.2 Glecan Main Business
7.9.3 Glecan Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.9.4 Glecan Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.9.5 Glecan Recent Developments
7.10 Xinkangyx
7.10.1 Xinkangyx Profile
7.10.2 Xinkangyx Main Business
7.10.3 Xinkangyx Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.10.4 Xinkangyx Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.10.5 Xinkangyx Recent Developments
7.11 WonderLab
7.11.1 WonderLab Profile
7.11.2 WonderLab Main Business
7.11.3 WonderLab Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.11.4 WonderLab Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.11.5 WonderLab Recent Developments
7.12 BestCovered, Ltd.
7.12.1 BestCovered, Ltd. Profile
7.12.2 BestCovered, Ltd. Main Business
7.12.3 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
7.12.4 BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Revenue (US$ Million) & (2019-2024)
7.12.5 BestCovered, Ltd. Recent Developments
8 Industry Chain Analysis
8.1 Digital Therapeutics for Nervous System Diseases Industrial Chain
8.2 Digital Therapeutics for Nervous System Diseases Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Digital Therapeutics for Nervous System Diseases Sales Model
8.5.2 Sales Channel
8.5.3 Digital Therapeutics for Nervous System Diseases Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Digital Therapeutics for Nervous System Diseases Market Trends
Table 2. Digital Therapeutics for Nervous System Diseases Market Drivers & Opportunity
Table 3. Digital Therapeutics for Nervous System Diseases Market Challenges
Table 4. Digital Therapeutics for Nervous System Diseases Market Restraints
Table 5. Global Digital Therapeutics for Nervous System Diseases Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Digital Therapeutics for Nervous System Diseases Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Digital Therapeutics for Nervous System Diseases Product Type
Table 9. Key Companies Time to Begin Mass Production of Digital Therapeutics for Nervous System Diseases
Table 10. Global Digital Therapeutics for Nervous System Diseases Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024) & (%)
Table 27. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value, (2025-2030) & (US$ Million)
Table 31. Zoecare Basic Information List
Table 32. Zoecare Description and Business Overview
Table 33. Zoecare Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 34. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Zoecare (2019-2024)
Table 35. Zoecare Recent Developments
Table 36. 66nao Basic Information List
Table 37. 66nao Description and Business Overview
Table 38. 66nao Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 39. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of 66nao (2019-2024)
Table 40. 66nao Recent Developments
Table 41. MedRhythms Basic Information List
Table 42. MedRhythms Description and Business Overview
Table 43. MedRhythms Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 44. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of MedRhythms (2019-2024)
Table 45. MedRhythms Recent Developments
Table 46. Curelator Basic Information List
Table 47. Curelator Description and Business Overview
Table 48. Curelator Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 49. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Curelator (2019-2024)
Table 50. Curelator Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 54. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. GYENNO SCIENCE Basic Information List
Table 57. GYENNO SCIENCE Description and Business Overview
Table 58. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 59. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of GYENNO SCIENCE (2019-2024)
Table 60. GYENNO SCIENCE Recent Developments
Table 61. Cognito Therapeutics Basic Information List
Table 62. Cognito Therapeutics Description and Business Overview
Table 63. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 64. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Cognito Therapeutics (2019-2024)
Table 65. Cognito Therapeutics Recent Developments
Table 66. Nanjing Vishee Medical Technology Co.,Ltd. Basic Information List
Table 67. Nanjing Vishee Medical Technology Co.,Ltd. Description and Business Overview
Table 68. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 69. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Nanjing Vishee Medical Technology Co.,Ltd. (2019-2024)
Table 70. Nanjing Vishee Medical Technology Co.,Ltd. Recent Developments
Table 71. Glecan Basic Information List
Table 72. Glecan Description and Business Overview
Table 73. Glecan Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 74. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Glecan (2019-2024)
Table 75. Glecan Recent Developments
Table 76. Xinkangyx Basic Information List
Table 77. Xinkangyx Description and Business Overview
Table 78. Xinkangyx Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 79. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Xinkangyx (2019-2024)
Table 80. Xinkangyx Recent Developments
Table 81. WonderLab Basic Information List
Table 82. WonderLab Description and Business Overview
Table 83. WonderLab Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 84. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of WonderLab (2019-2024)
Table 85. WonderLab Recent Developments
Table 86. BestCovered, Ltd. Basic Information List
Table 87. BestCovered, Ltd. Description and Business Overview
Table 88. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 89. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of BestCovered, Ltd. (2019-2024)
Table 90. BestCovered, Ltd. Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Digital Therapeutics for Nervous System Diseases Downstream Customers
Table 94. Digital Therapeutics for Nervous System Diseases Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Digital Therapeutics for Nervous System Diseases Product Picture
Figure 2. Global Digital Therapeutics for Nervous System Diseases Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 4. Digital Therapeutics for Nervous System Diseases Report Years Considered
Figure 5. Global Digital Therapeutics for Nervous System Diseases Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Digital Therapeutics for Nervous System Diseases Revenue in 2023
Figure 7. Digital Therapeutics for Nervous System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Prevention Picture
Figure 9. Management Picture
Figure 10. Treatment Picture
Figure 11. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Digital Therapeutics for Nervous System Diseases Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Epilepsy
Figure 14. Product Picture of Parkinson's Disease
Figure 15. Product Picture of Alzheimer's Disease
Figure 16. Product Picture of Other
Figure 17. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Digital Therapeutics for Nervous System Diseases Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value (%), (2019-2030)
Figure 30. United States Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 36. China Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 38. China Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 48. India Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 50. India Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 51. Digital Therapeutics for Nervous System Diseases Industrial Chain
Figure 52. Digital Therapeutics for Nervous System Diseases Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Table 1. Digital Therapeutics for Nervous System Diseases Market Trends
Table 2. Digital Therapeutics for Nervous System Diseases Market Drivers & Opportunity
Table 3. Digital Therapeutics for Nervous System Diseases Market Challenges
Table 4. Digital Therapeutics for Nervous System Diseases Market Restraints
Table 5. Global Digital Therapeutics for Nervous System Diseases Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Digital Therapeutics for Nervous System Diseases Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Digital Therapeutics for Nervous System Diseases Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Digital Therapeutics for Nervous System Diseases Product Type
Table 9. Key Companies Time to Begin Mass Production of Digital Therapeutics for Nervous System Diseases
Table 10. Global Digital Therapeutics for Nervous System Diseases Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Therapeutics for Nervous System Diseases as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Digital Therapeutics for Nervous System Diseases Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2019-2024) & (%)
Table 27. Global Digital Therapeutics for Nervous System Diseases Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value, (2025-2030) & (US$ Million)
Table 31. Zoecare Basic Information List
Table 32. Zoecare Description and Business Overview
Table 33. Zoecare Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 34. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Zoecare (2019-2024)
Table 35. Zoecare Recent Developments
Table 36. 66nao Basic Information List
Table 37. 66nao Description and Business Overview
Table 38. 66nao Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 39. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of 66nao (2019-2024)
Table 40. 66nao Recent Developments
Table 41. MedRhythms Basic Information List
Table 42. MedRhythms Description and Business Overview
Table 43. MedRhythms Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 44. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of MedRhythms (2019-2024)
Table 45. MedRhythms Recent Developments
Table 46. Curelator Basic Information List
Table 47. Curelator Description and Business Overview
Table 48. Curelator Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 49. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Curelator (2019-2024)
Table 50. Curelator Recent Developments
Table 51. Sanofi Basic Information List
Table 52. Sanofi Description and Business Overview
Table 53. Sanofi Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 54. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Sanofi (2019-2024)
Table 55. Sanofi Recent Developments
Table 56. GYENNO SCIENCE Basic Information List
Table 57. GYENNO SCIENCE Description and Business Overview
Table 58. GYENNO SCIENCE Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 59. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of GYENNO SCIENCE (2019-2024)
Table 60. GYENNO SCIENCE Recent Developments
Table 61. Cognito Therapeutics Basic Information List
Table 62. Cognito Therapeutics Description and Business Overview
Table 63. Cognito Therapeutics Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 64. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Cognito Therapeutics (2019-2024)
Table 65. Cognito Therapeutics Recent Developments
Table 66. Nanjing Vishee Medical Technology Co.,Ltd. Basic Information List
Table 67. Nanjing Vishee Medical Technology Co.,Ltd. Description and Business Overview
Table 68. Nanjing Vishee Medical Technology Co.,Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 69. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Nanjing Vishee Medical Technology Co.,Ltd. (2019-2024)
Table 70. Nanjing Vishee Medical Technology Co.,Ltd. Recent Developments
Table 71. Glecan Basic Information List
Table 72. Glecan Description and Business Overview
Table 73. Glecan Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 74. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Glecan (2019-2024)
Table 75. Glecan Recent Developments
Table 76. Xinkangyx Basic Information List
Table 77. Xinkangyx Description and Business Overview
Table 78. Xinkangyx Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 79. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of Xinkangyx (2019-2024)
Table 80. Xinkangyx Recent Developments
Table 81. WonderLab Basic Information List
Table 82. WonderLab Description and Business Overview
Table 83. WonderLab Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 84. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of WonderLab (2019-2024)
Table 85. WonderLab Recent Developments
Table 86. BestCovered, Ltd. Basic Information List
Table 87. BestCovered, Ltd. Description and Business Overview
Table 88. BestCovered, Ltd. Digital Therapeutics for Nervous System Diseases Products, Services and Solutions
Table 89. Revenue (US$ Million) in Digital Therapeutics for Nervous System Diseases Business of BestCovered, Ltd. (2019-2024)
Table 90. BestCovered, Ltd. Recent Developments
Table 91. Key Raw Materials Lists
Table 92. Raw Materials Key Suppliers Lists
Table 93. Digital Therapeutics for Nervous System Diseases Downstream Customers
Table 94. Digital Therapeutics for Nervous System Diseases Distributors List
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
Table 98. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Digital Therapeutics for Nervous System Diseases Product Picture
Figure 2. Global Digital Therapeutics for Nervous System Diseases Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 4. Digital Therapeutics for Nervous System Diseases Report Years Considered
Figure 5. Global Digital Therapeutics for Nervous System Diseases Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Digital Therapeutics for Nervous System Diseases Revenue in 2023
Figure 7. Digital Therapeutics for Nervous System Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Prevention Picture
Figure 9. Management Picture
Figure 10. Treatment Picture
Figure 11. Global Digital Therapeutics for Nervous System Diseases Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Digital Therapeutics for Nervous System Diseases Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Epilepsy
Figure 14. Product Picture of Parkinson's Disease
Figure 15. Product Picture of Alzheimer's Disease
Figure 16. Product Picture of Other
Figure 17. Global Digital Therapeutics for Nervous System Diseases Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 18. Global Digital Therapeutics for Nervous System Diseases Sales Value Market Share by Application, 2023 & 2030
Figure 19. North America Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 20. North America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 21. Europe Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 22. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 23. Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 24. Asia Pacific Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 25. South America Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 26. South America Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 27. Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value (2019-2030) & (US$ Million)
Figure 28. Middle East & Africa Digital Therapeutics for Nervous System Diseases Sales Value by Country (%), 2023 VS 2030
Figure 29. Key Countries/Regions Digital Therapeutics for Nervous System Diseases Sales Value (%), (2019-2030)
Figure 30. United States Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 31. United States Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 32. United States Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 33. Europe Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 34. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 35. Europe Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 36. China Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 37. China Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 38. China Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 39. Japan Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 40. Japan Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 41. Japan Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 42. South Korea Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 43. South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 44. South Korea Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 45. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 46. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 47. Southeast Asia Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 48. India Digital Therapeutics for Nervous System Diseases Sales Value, (2019-2030) & (US$ Million)
Figure 49. India Digital Therapeutics for Nervous System Diseases Sales Value by Type (%), 2023 VS 2030
Figure 50. India Digital Therapeutics for Nervous System Diseases Sales Value by Application (%), 2023 VS 2030
Figure 51. Digital Therapeutics for Nervous System Diseases Industrial Chain
Figure 52. Digital Therapeutics for Nervous System Diseases Manufacturing Cost Structure
Figure 53. Channels of Distribution (Direct Sales, and Distribution)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Vibrating Viscometer Market Insights, Forecast to 2030
Dec 16, 24
Global Specialty Hoses Market Insights, Forecast to 2030
Dec 16, 24
Global Recreational Fiberglass Boat Market Insights, Forecast to 2030
Dec 16, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232